Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (161-170 of 238) with videos related to

Pageof 24
Sort By:
International Journal of Molecular Sciences|September 29, 2020
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher DiseaseYishay Weill, Ari Zimran, David Zadok, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
Plos One|March 12, 2009
A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigationDavid Aviezer, Einat Brill-Almon, Yoseph Shaaltiel, et al.
Journal of Clinical Medicine|October 17, 2019
Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher DiseaseTama Dinur, Ari Zimran, Michal Becker-Cohen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imigluceraseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|January 25, 2011
Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genesEva Svobodová, Lenka Mrázová, Ondřej Lukšan, et al.
American Journal of Hematology|April 1, 2004
Rheological determinants in patients with Gaucher disease and internal inflammationAri Zimran, Amir Bashkin, Deborah Elstein, et al.
International Journal of Molecular Sciences|February 25, 2023
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher DiseaseTama Dinur, Peter Bauer, Christian Beetz, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher diseaseGregory M Pastores, Hadhami Ben Turkia, Derlis E Gonzalez, et al.
American Journal of Medical Genetics|July 13, 2002
C7 complement deficiency in an Israeli Arab villageDoron Behar, Menachem Schlesinger, David Halle, et al.
Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:
Pageof 24
International Journal of Molecular Sciences|September 29, 2020
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher DiseaseYishay Weill, Ari Zimran, David Zadok, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
Plos One|March 12, 2009
A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigationDavid Aviezer, Einat Brill-Almon, Yoseph Shaaltiel, et al.
Journal of Clinical Medicine|October 17, 2019
Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher DiseaseTama Dinur, Ari Zimran, Michal Becker-Cohen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imigluceraseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|January 25, 2011
Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genesEva Svobodová, Lenka Mrázová, Ondřej Lukšan, et al.
American Journal of Hematology|April 1, 2004
Rheological determinants in patients with Gaucher disease and internal inflammationAri Zimran, Amir Bashkin, Deborah Elstein, et al.
International Journal of Molecular Sciences|February 25, 2023
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher DiseaseTama Dinur, Peter Bauer, Christian Beetz, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher diseaseGregory M Pastores, Hadhami Ben Turkia, Derlis E Gonzalez, et al.
American Journal of Medical Genetics|July 13, 2002
C7 complement deficiency in an Israeli Arab villageDoron Behar, Menachem Schlesinger, David Halle, et al.
Pageof 24